GlobeNewswire - News from Maryland

ABT APPRAISED AT CMMI-LEVEL 2-DEV

Fri, 05 Mar 2021 14:00 GMT

AFFIRMS RIGOROUS PROCESSES AND COMMITMENT TO CONTINUOUS IMPROVEMENT

AFFIRMS RIGOROUS PROCESSES AND COMMITMENT TO CONTINUOUS IMPROVEMENT

NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

Thu, 04 Mar 2021 21:05 GMT

BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today reported fourth quarter and full year 2020 financial results and provided a business update.

Media urged to recognize shift from “Autism Awareness Month” to “Autism Acceptance Month” this April

Thu, 04 Mar 2021 18:00 GMT

Autism community calls on media to move from using “awareness” to “acceptance” this April to foster change and inclusivity for those affected by autism.

Autism community calls on media to move from using “awareness” to “acceptance” this April to foster change and inclusivity for those affected by autism.

PSI Launches State-of-the-Art Innovation Facility in Florida

Thu, 04 Mar 2021 16:40 GMT

ARLINGTON, Va., March 04, 2021 (GLOBE NEWSWIRE) -- Planned Systems International, Inc. (PSI)—a leading provider of enterprise technology solutions and services to the federal government—proudly announces the launch of the PSI Innovation Facility, a collaborative workspace designed to provide strategic and timely technical capabilities, illustrating the company’s commitment to deliver excellence to its customers.

Cerecor to Present at Upcoming Investor Conferences

Thu, 04 Mar 2021 12:00 GMT

ROCKVILLE, Md. and CHESTERBROOK, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced that Michael F. Cola, President and Chief Executive Officer, will present at two upcoming virtual conferences.

Repeat: Colfax Announces Intention to Separate Into Two Independent Public Companies

Thu, 04 Mar 2021 11:41 GMT

Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) -- ?– Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.

Colfax Announces Intention to Separate Into Two Independent Public Companies

Thu, 04 Mar 2021 11:00 GMT

James Burke Named President of the Community Financial Corporation, Community Bank of the Chesapeake Holding Company

Wed, 03 Mar 2021 22:24 GMT

WALDORF, Md., March 03, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of Community Financial Corporation (“TCFC” or the “Company”), the holding company of Community Bank of the Chesapeake (“CBTC” or the “Bank”), has named James M. Burke as President of the Company, effective February 25, 2021. Jimmy is a banking veteran and currently serves as President of Community Bank of the Chesapeake. William Pasenelli, who has served as CEO and President of the Company, will continue to serve as Chief Executive Officer of the Company.

World Hearing Day is Today, March 3

Wed, 03 Mar 2021 19:13 GMT

New Research Shows 80% of Us Consider Hearing Loss Serious, So Why Do We Ignore It?

New Research Shows 80% of Us Consider Hearing Loss Serious, So Why Do We Ignore It?

New Report shows OSW renewables has potential to be next great industry

Wed, 03 Mar 2021 17:32 GMT

The Business Network’s annual U.S. Offshore Wind Market Report analyzes Biden Administration policies affecting the offshore wind renewable energy industry, opportunities for growth, supply chain expansion, and more

The Business Network’s annual U.S. Offshore Wind Market Report analyzes Biden Administration policies affecting the offshore wind renewable energy industry, opportunities for growth, supply chain expansion, and more

MICHELE LAIRD PROMOTED TO REGIONAL VICE PRESIDENT, INTERNATIONAL DEVELOPMENT DIVISION, ABT ASSOCIATES

Wed, 03 Mar 2021 16:00 GMT

Rockville, MD, March 03, 2021 (GLOBE NEWSWIRE) -- Abt Associates announced that Michèle Olivier Laird has been promoted to regional vice president in the International Development Division (IDD).

Mercaris Inks Global Redistribution Agreements for Organic Cash Prices

Wed, 03 Mar 2021 14:15 GMT

Organic and non-GMO leader expands reach through multiple platforms

Organic and non-GMO leader expands reach through multiple platforms

REMINDER: NextCure to Host Virtual R&D Update Event on March 4, 2021

Tue, 02 Mar 2021 21:05 GMT

BELTSVILLE, Md., March 02, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will host a Virtual R&D Update Event at 5:00 p.m. ET on Thursday, March 4.

NexImmune to Present at the 2021 Barclays Global Healthcare Conference

Tue, 02 Mar 2021 21:01 GMT

GAITHERSBURG, Md., March 02, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc.?(Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that?Scott Carmer, Chief Executive Officer, will present a company overview at the?virtual 2021 Barclays Global Healthcare Conference on?Thursday, March 11, 2021?at?10:55 a.m. Eastern time.

Partners Bancorp Reports Results of Operations for the Fourth Quarter 2020

Tue, 02 Mar 2021 13:15 GMT

SALISBURY, Md., March 02, 2021 (GLOBE NEWSWIRE) -- Partners Bancorp (NASDAQ: PTRS) (the “Company”), the parent company of The Bank of Delmarva (“Delmarva”), Seaford, Delaware, and Virginia Partners Bank (“Virginia Partners”), Fredericksburg, Virginia, reported net income attributable to the Company of $1.1 million, or $0.06 per share, for the three months ended December 31, 2020, a $156 thousand or 16.4% increase when compared to net income attributable to the Company of $950 thousand, or $0.07 per share, for the same period in 2019. For the twelve months ended December 31, 2020, the Company reported net income attributable to the Company of $5.7 million, or $0.32 per share, a $215 thousand or 3.7% decrease when compared to net income attributable to the Company of $5.9 million, or $0.54 per share, for the same period in 2019. The Company’s results of operations for the three and twelve months ended December 31, 2020 were directly impacted by the acquisition of Virginia Partners, whose results of operations were not fully present for the same periods of 2019, and significantly higher provision for credit losses due to the current economic environment and to the COVID-19 pandemic.

Cerecor Announces CERC-002 Significantly Reduced Respiratory Failure and Mortality in Phase 2 Clinical Trial in Patients Hospitalized with COVID-19 ARDS

Tue, 02 Mar 2021 12:00 GMT

ROCKVILLE, Md. and CHESTERBROOK, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced final efficacy data including 60-day mortality from their recently completed US-based, multi-center (10 sites), Phase 2 trial (NCT04412057) of the human anti-LIGHT (TNFSF14) monoclonal antibody CERC-002. This analysis updates the preliminary topline data reported on January 5, 2021. All patients in this trial were hospitalized with COVID-19 associated pneumonia and mild-to-moderate acute respiratory distress syndrome (“ARDS”). A total of 83 patients were randomized 1:1 to receive standard of care at the sites plus either a single dose of 1,200 mg of CERC-002 or placebo subcutaneously. Due to the protocol allowing patients to receive high flow oxygen prior to randomization, 62 patients were included in the intention-to-treat (ITT) analysis of the primary endpoint.

Royal Farms Gifts $25,000 of PPE to Local Restaurants

Mon, 01 Mar 2021 21:32 GMT

BALTIMORE, March 01, 2021 (GLOBE NEWSWIRE) -- Royal Farms announced a donation of personal protective equipment, totaling $25,000, to the “Famous Fund” created by Baltimore area restaurant, Jimmy’s Famous Seafood.

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

Mon, 01 Mar 2021 21:05 GMT

SILVER SPRING, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today reported financial results for the fourth quarter and full year ended December 31, 2020.

Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights

Mon, 01 Mar 2021 21:02 GMT

GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced its financial results and operational highlights for the fourth quarter and twelve months ended December 31, 2020.

Viela Bio Reports Fourth Quarter and Full Year 2020 Operating and Financial Results

Mon, 01 Mar 2021 21:01 GMT

GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Viela Bio?(Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today reported financial results and provided program and business highlights for the fourth quarter and full year ended December 31, 2020.